Humana Inc. (NYSE: HUM) is -24.12% lower on its value in year-to-date trading and has touched a low of $334.54 and a high of $541.21 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HUM stock was last observed hovering at around $348.19 in the last trading session, with the day’s loss setting it -0.8%.
Currently trading at $347.39, the stock is -0.64% and -7.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.4 million and changing -0.23% at the moment leaves the stock -23.38% off its SMA200. HUM registered -30.64% loss for a year compared to 6-month loss of -28.34%. The firm has a 50-day simple moving average (SMA 50) of $0.46.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.50% gain in the last 1 month and extending the period to 3 months gives it a -25.06%, and is -0.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.44% over the week and 2.11% over the month.
Humana Inc. (HUM) has around 67600 employees, a market worth around $41.88B and $106.37B in sales. Current P/E ratio is 17.52 and Fwd P/E is 14.29. Profit margin for the company is 2.34%. Distance from 52-week low is 3.84% and -35.81% from its 52-week high. The company has generated returns on investments over the last 12 months (9.25%).
Humana Inc. quarterly earnings per share for the current quarter are estimated at $6.16 with sales reaching $28.35B over the same period.The EPS is expected to shrink by -34.78% this year, but quarterly earnings will post 8.60% year-over-year. Quarterly sales are estimated to grow 10.50% in year-over-year returns.
1,606 institutions hold shares in Humana Inc. (HUM), with institutional investors hold 94.32% of the company’s shares. The shares outstanding are 122.22M, and float is at 120.12M with Short Float at 1.87%. Institutions hold 94.12% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 11.26 million shares valued at $5.03 billion. The investor’s holdings represent 9.08% of the HUM Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 10.63 million shares valued at $4.75 billion to account for 8.58% of the shares outstanding. The other top investors are Price (T.Rowe) Associates Inc which holds 7.23 million shares representing 5.83% and valued at over $3.23 billion, while FMR, LLC holds 5.74% of the shares totaling 7.12 million with a market value of $3.18 billion.
Humana Inc. (HUM) Insider Activity
The most recent transaction is an insider purchase by Mesquita Jorge S., the company’s Director. SEC filings show that Mesquita Jorge S. bought 545 shares of the company’s common stock on Feb 20 ’24 at a price of $367.09 per share for a total of $0.2 million. Following the purchase, the insider now owns 2578.0 shares.
Humana Inc. disclosed in a document filed with the SEC on May 04 ’23 that Diamond Susan M (Chief Financial Officer) sold a total of 4,156 shares of the company’s common stock. The trade occurred on May 04 ’23 and was made at $526.28 per share for $2.19 million. Following the transaction, the insider now directly holds 3931.0 shares of the HUM stock.
